Keyphrases
Natural Killer Cells
88%
Chimeric Antigen Receptor T Cells (CAR-T)
47%
Effective Approach
47%
Solid Tumors
47%
Stress Proteins
47%
DNAM-1
47%
Tag Games
47%
Alternative Programs
47%
Natural Killer Cell Maturation
47%
Tumor
47%
Melanoma Metastasis
47%
Malignant Cells
47%
Inhalation Therapy
47%
Experimental Melanoma
47%
Cell-to-cell
47%
Melanoma Development
47%
Tumor Cells
37%
Pulmonary Metastatic Melanoma
23%
Melanoma Growth
23%
Patient Benefit
23%
Lung Tissue
23%
Potential Gains
23%
Single Therapy
23%
Tumor Analysis
23%
Immunomodulatory Properties
23%
Cancer Patients
23%
Complementary Therapies
23%
Angiotensin II Type 1 Receptor (AT1R)
23%
Current Therapies
23%
Sustained Response
23%
Angiogenesis
23%
Subcutaneous Tissue
23%
Growth Model
23%
Response Rate
23%
B16F10 Melanoma Cells
23%
C57BL
23%
Low Toxicity
23%
Euthanized
23%
Multi-parameter
23%
Melanoma Model
23%
Melanoma Patients
23%
Melanoma Treatment
23%
Chemotherapeutic Approaches
23%
Myeloid-derived Suppressor Cells
23%
Low Tumor Burden
23%
Metastatic Melanoma
23%
Effective Alternative
23%
Anti-melanoma
23%
DNA Damage
21%
Soluble MICA
21%
Medicine and Dentistry
Malignant Neoplasm
71%
Neoplasm
67%
Natural Killer Cell
54%
Solid Malignant Neoplasm
47%
Inhalational Drug Administration
47%
Metastatic Carcinoma
47%
Chimeric Antigen Receptor
47%
Experimental Melanoma
47%
Heat Shock Protein
47%
Melanoma
47%
Tumor Cell
38%
Receptor
34%
Oncology
31%
Metastatic Melanoma
23%
DNA Damage
22%
Immunity
22%
Virus Infection
15%
Proteinase
15%
Cellular Stress Response
15%
Blood Plasma
15%
Cancer Cell
15%
Target Cell
15%
Immunological Tolerance
15%
Extracellular Space
15%
Immunotherapy
15%
Protein Processing
15%
Malignant Transformation
15%
Clinical Significance
15%
Lymphocyte
15%
Fc Receptor
13%
Antigen Specificity
13%
C57BL/6
11%
Myeloid-Derived Suppressor Cell
11%
Medicine
11%
Health Care Cost
11%
Angiogenesis
11%
Melanoma Cell
11%
Subcutaneous Tissue
11%
Angiotensin II
11%
Complementary Therapy
11%
Lung
11%
Hematologic Malignancy
6%
Chimeric Antigen Receptor T-Cell Immunotherapy
6%
Chimeric Antigen Receptor T-Cell
6%
Induced Pluripotent Stem Cell
6%
Clinical Assessment
6%
Xenograft
6%
Cancer Immunotherapy
6%
Cancer Cell Line
6%
Biochemistry, Genetics and Molecular Biology
Natural Killer Cell
100%
Cell Maturation
47%
Heat Shock Protein
47%
Chimeric Antigen Receptor
47%
DNA Damage
21%
Cancer Cell
21%
Immunity
21%
Target Cell
15%
Posttranslational Modification
15%
Malignant Transformation
15%
Cellular Stress Response
15%
Immunological Tolerance
15%
Serum (Blood)
15%
Blood Plasma
15%
Lymphocyte
15%
Protease
15%
Antigen Specificity
10%
Fc Receptor
10%
CD16
10%
T Cell
10%
Cancer Immunotherapy
5%
Interleukin 15
5%
Infectious Agent
5%
Gene Expression Profiling
5%
Induced Pluripotent Stem Cell
5%
Inflammatory Cytokine
5%
Chemokine
5%
Therapeutic Antibodies
5%
CD226
5%